**Question:** All of the following are examples of tumor markers, except-

A. Carcinoembryonic antigen (CEA)
B. Prostate-specific antigen (PSA)
C. Alpha-fetoprotein (AFP)
D. Cancer antigen 19-9 (CA-19-9)

**Correct Answer:** **A. Prostate-specific antigen (PSA)**

**Core Concept:** Tumor markers are substances that increase or decrease in the blood or body fluids in response to the presence or growth of cancer cells or other diseases. They are useful in diagnosing, monitoring, and prognosticating cancer.

**Why the Correct Answer is Right:** Prostate-specific antigen (PSA) is a protein produced by the prostate gland, not by cancer cells. In the context of prostate cancer, an elevated PSA level indicates prostate tissue damage or inflammation rather than cancer itself. Thus, it is not a tumor marker specific to cancer but rather a response to prostate inflammation or injury.

**Why Each Wrong Option is Incorrect:**

**A. Carcinoembryonic antigen (CEA):** CEA is a tumor marker that increases in various types of cancer, including colon, breast, lung, and pancreatic cancers. It is not specific to prostate cancer, making it a correct tumor marker example.

**B. Alpha-fetoprotein (AFP):** AFP is elevated in cases of liver cancer, yolk sac tumors, and neural tube defects. It is not specific to prostate cancer, making it a correct tumor marker example.

**C. Cancer antigen 19-9 (CA-19-9):** CA-19-9 is associated with pancreatic, ovarian, biliary, and gastrointestinal tract cancers. It is not specific to prostate cancer, making it a correct tumor marker example.

**Clinical Pearl:** Tumor markers should ideally be specific to the type of cancer in question to be clinically useful. The correct tumor markers for prostate cancer are CEA, PSA, and prostate-specific acid phosphatase (PSAP).

**Core Concept:** Tumor markers are proteins, enzymes, or other substances that increase or decrease in the blood or body fluids in response to the presence or growth of cancer cells or other diseases. They are used for diagnosing, monitoring, and predicting cancer progression.

**Why the Correct Answer is Right:** Prostate-specific antigen (PSA) is used as a prostate cancer marker, but it is not a specific marker for prostate cancer. It is elevated in cases of prostate inflammation or prostatitis, making it unsuitable for diagnosing prostate cancer.

**Why Each Wrong Option is Incorrect:**

**A. Carcinoembryonic antigen (CEA):** CEA is a tumor marker that increases in various types of cancer, including colon, breast, lung, and neuroendocrine tumors. Its use in diagnosing prostate cancer is limited.

**B. Alpha-fetoprotein (AFP):** AFP is associated with pancreatic, ovarian, biliary, and gastrointestinal tract cancers. Its use in diagnosing prostate cancer is limited.

**C. Cancer antigen 19-9 (CA-19